An inverse probability of treatment weighted comparison between vedolizumab, ustekinumab, and tofacitinib in anti-TNF-experienced ulcerative colitis patients. - Tursi A; Pasta A; Elisei W; Barberio B; Bertin L; Mocci G; Maconi G; Gravina AG; Pellegrino R; Bodini G; Papa A; Savarino EV (Therapeutic advances in gastroenterology, 2026)